BIC is an integrase strand transfer inhibitor that has a higher barrier to resistance and is only used in combination. LEN has been approved as a method of pre-exposure prophylaxis but has also been ...
Chemoradiotherapy (CRT) was preferred to radiotherapy alone in patients older than 65 years who had stage II nonsurgical non–small cell lung cancer (NSCLC), as overall survival (OS) and ...
A significant number of people with rheumatoid arthritis (RA) experience financial distress, particularly if they also suffer ...
Presented at the American Heart Association (AHA) 2025 Scientific Sessions, the new guidelines emphasize tighter systolic BP ...
Immunoglobulin heavy chain variable ( IGHV) testing has become an important prognostic and therapeutic factor in chronic ...
“Identifying the causes and risk factors of MS and substantiating the effectiveness of certain interventions are both crucial ...
The Food Inflammation Index (FII) shows a significant linear relationship with MASLD risk, outperforming the Dietary ...
Panelists discuss how aligning evolving payer policies with real-world oncology practice is key to sustaining timely and ...
Ochsner Health, in partnership with MD Anderson, has established multiple cancer centers throughout the state of Louisiana, ...
The US pharmaceutical supply chain relies heavily on imports, with roughly 80% of APIs sourced from China and India. 2 Tariffs could raise input costs, trigger retaliatory trade measures, or ...
Papillary muscle scarring (papSCAR) as detected by dark blood delayed-enhancement cardiovascular magnetic resonance (CMR) was ...
Panelists discuss how removing LDL-C targets in 2013 shifted focus from outcomes to statin use, weakening control efforts.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results